Live Breaking News & Updates on Central Drug Standard Control|Page 2

Bharat Biotech Covaxin Not Approved: Experts
by Hannah Joy on 
January 2, 2021 at 7:26 PM
Bharat Biotech s data for its coronavirus vaccine called Covaxin was found to be insufficient for grant of emergency use approval, said the Subject Expert Committee of the Central Drug Standard Control Organisation.
Earlier on Friday, the expert committee, which is tasked with vetting covid-19 vaccine proposals, recommended emergency licensure for the Serum Institute of India-manufactured Covishield . It become the first vaccine to secure recommendation for emergency use in India.
The Pune-based Serum Institute has partnered with Oxford-AstraZeneca for conducting clinical trials and manufacturing Covishield while Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) for Covaxin . ....

Serum Institute Of Covishield , Bharat Biotech , Subject Expert Committee , Central Drug Standard Control , Serum Institute , பாரத் பயோடெக் , பொருள் நிபுணர் குழு , மைய மருந்து தரநிலை கட்டுப்பாடு , சீரம் நிறுவனம் ,